25807nam a22007095i 45000010014000000030009000140050017000230060019000400070015000590080041000740200018001150240031001330350020001640350022001840400033002060410008002390440011002470500026002580720023002840820017003072450319003242500017006432640046006602640011007063000046007173360026007633370026007893380036008153470024008514900045008755057796009205058334087165056920170505060104239705300026240745380049241005460016241495880112241656500028242776500032243057000075243377000087244127000078244997730109245777760025246868560042247118560049247538560080248029120016248829120014248989120017249129120015249299120016249449120016249609120015249769120024249919120014250159120014250299120015250439120012250589120027250709783110889000DE-B159720221201113901.0m|||||o||d||||||||cr || ||||||||221201t20191990gw     fo  d z      eng d  a97831108890007 a10.1515/97831108890002doi  a(DE-B1597)54621  a(OCoLC)1135590935  aDE-B1597bengcDE-B1597erda0 aeng  agwcDE 4aQP801.P69b.C446 1990 7aSCI0000002bisacsh04a574.192422300aChemistry and Biology of Pteridines :bPteridines and Folic Acid Derivatives. Proceedings of the International Symposium on Pteridines and Folic Acid Derivatives, Chemical, Biological and Clinical Aspects. n9, pZurich, Switzerland, September 3-8, 1989 /ced. by Hans-Christoph Curtius, Nenad Blau, Sandro Ghisla.  aReprint 2019 1aBerlin ;aBoston : bDe Gruyter, c[2019] 4c©1990  a1 online resource (1340 p.) :bNum. figs.  atextbtxt2rdacontent  acomputerbc2rdamedia  aonline resourcebcr2rdacarrier  atext filebPDF2rda0 aChemistry and Biology of Pteridines ;v900tFrontmatter -- tPreface -- tAdrien Albert -- tAlois Niederwieser -- tTetsuo Shiota -- tContents -- tI CHEMISTRY OF PTERINS AND FOLATES -- tRecent progress in pteridine chemistry -- tSynthesis of pteridines for immunoassay of biopterin and neopterin isomers -- tDesign of new mechanism-based substrates for dihydrofolate reductase -- tNew methods for the synthesis of quinazoline antifolates and poly-y-glutamyl metabolites of folates and antifolates -- tThe decay of quinoid- and 7,8-dihydropterins -- tSynthesis of 6-acetyl-2,4-diamino-7,8-dihydro-9//-pyrimido-[4,5-b][l,4]- diazepine, an amino analog of 6-acetyldihydrohomopterin -- tSynthetic approaches to methanopterin -- tSynthesis and properties of tetrahydropterins coupled to 1,4-dihydropyridines -- tA new synthesis of biopterin and some analogues from epoxyaldehydes -- tSynthetic studies on the molybdenum cofactor -- tA new regiospecific synthesis of anapterin and primapterin -- tA novel and efficient synthesis of folylpolyglutamates -- tReaction of acidic anhydride and pyridine with folic acid and classical antifolates -- tQuinazoline antifolate thymidylate synthase inhibitors: Synthesis of analogues containing heterocyclic isosteres of the para-aminobenzoate unit -- tSynthesis of tetrahydro-8-deazabiopterin -- tSynthesis and enzymic properties of new mechanism based substrates for dihydrofolate reductase of the 8-substituted pterin class. -- tImidazolines as carbon-transfer vehicles: models of the tetrahydrofolate (and other) coenzymes -- tAsymmetric synthesis and absolute configuration of 5,10-dideaza- 5,6,7,8-tetrahydropteroic acid and 5,10-dideaza-5,6,7,8-tetrahydrofolic acid -- tSynthesis and biological evaluation of a fluorescent analogue of folic acid -- tMetal complexes of tetrahydroneopterin -- tSyntheses of lipophilic analogues of 2-desamino-2-CH3-NIO-propargyl- 5,8-dideazafolate targeted at the enzyme thymidylate synthase (TS). -- tStudies in models of folate cofactors: oxidation of 5-methyltetrahydropterin revisited. -- tNew strategy in the synthesis of neopterin phosphates -- tFirst regiospecific synthesis of 7-iso-D-neopterin and 7-iso-D-neopterin- 3 '-monophosphate -- tII. ANALYSIS OF PTERINS AND FOLATES -- tDetection of pterins in biological material using mass spectrometry -- tMass spectrometric methods for the structural determination of pteridines and folic acid derivatives -- tStructural characterization of underivatized pteridines by laser desorption fourier transform mass spectrometry -- tNew immunoassays for determination of biopterin and neopterin in body fluids -- tA new immunoassay for neopterin and biopterin -- tEnzyme immunoassay for urinary neopterin -- tA competitive enzyme linked ligand sorbent assay (ELLSA) for quantitation of erythrocyte folates -- tPreparation of a bovine serum albumin based chiral matrix for resolution of (6R,S)-N5-formyltetrahydrofolate. -- tRp-HPLC methods for the isolation and chemical identification of pterins from monocytic blood cells -- tCyclodextrin based HPLC separation of 6-S and 6-R diastereomers of 5,10-dideaza and 5-deazatetrahydrofolates. -- tAnalysis of folate and antifolate metabolites by mass spectrometry -- tA critical assessment of methods for measuring folate in human serum and red blood cells. -- tHPLC analysis of intracellular folate compounds after enzymic conversion to the corresponding pteroates -- tIII. BIOSYNTHESIS AND BIOCHEMISTRY OF PTERINS -- tThe Gowland Hopkins Lecture: Biosynthesis of H4biopterin and related compounds -- tThe structure ofq-Bh2 - chemistry and biochemistry -- tPteridines in riboflavin biosynthesis -- tPteridine mimicking antibodies -- t6-Pyruvoyl-tetrahydropterin reductases -- tAnalysis of 6-pyruvoyl tetrahydropterin synthase, a target gene product of su(s) suppressor in Drosophila -- tSynthesis of fluorinated 8-ribityllumazines as "F NMR probes and potential inhibitors of the light riboflavin synthase of Bacillus subtilis -- tStudies on the oxidation state and biosynthesis of molybdopterin -- tMolybdenum cofactor genes in Drosophila -- tDNA photolyase: role of pterin in DNA repair. -- t7-Substituted pterins, a new class of mammalian pteridines -- tMethanopterin: A structural and functional folic acid analogon in the biochemistry of methanogenic bacteria. -- tBiosynthesis of methanopterin -- tTetrahydrobiopterin is required for the oxidation of arginine to nitric oxide by macrophages. -- tBiosynthesis of 7-hydroxybiopterin -- tGTP cyclohydrolase I from Escherichia coli. Molecular cloning and crystallization -- tMolecular characterization of the GTP cyclohydrolase I gene of Drosophila: analysis of cDNA clones -- tInhibitors of bovine adrenal medullary sepiapterin reductase -- tCatalytic implication of the reductase and isomerase activity of sepiapterin reductase in the biosynthesis of tetrahydrobiopterin -- tPurification and characterization of sepiapterin reductase from human liver -- tBiosynthesis of methanopterin and deazaflavin in Methanobacterium thermoautotrophicum -- tStudies on riboflavin synthases of Bacillus subtilis. Amino acid sequence of the a subunit -- tStructure of the lumazine synthase/riboflavin synthase complex of Bacillus subtilis: crystallization of hollow reconstitutß60, capsids. -- tBiosynthesis of 6,7-dimethyl-8-ribityllumazine. Purification and properties of 3,4-dihydroxy-2-butanone 4-phosphate synthase -- tHigh resolution electron microscopy on crystals of the icosahedral lumazine synthase/riboflavin synthase complex. -- tDifferential synthesis of LDH A-like proteins and of phosphoproteins in response to the modified deazaguanine-derivative queuine -- tMetabolic control in HeLa-cells mediated by the deazaguanine-derivative queuine -- tOn the biosynthesis of the deazaguanine-derivative queuine: structure of the tgt gene of E. coli -- tChanges in the level of biopterin and of queuine-containing tRNA during erythroid differentiation of murine erythroleukemia cells -- tBrain contents of biopterins and monoamines after intraperitoneal injections of SUN0588, active 6R-tetrahydrobiopterin, during ontogeny in rats -- tThe effect of 2,4-diamino-6-hydroxypyrimidine on tetrahydrobiopterin and serotonin in the gastrointestinal tract of mice. -- tDifferential metabolism of tetrahydrobiopterin in central and peripheral monoamine neurons maintained in culture -- tIV. TETRAHYDROBIOPTERIN DEFICIENCY -- tInborn errors in tetrahydrobiopterin metabolism -- tMolecular defects in dihydropteridine reductase deficiency -- tScreening and treatment of tetrahydrobiopterin deficiency -- tTetrahydrobiopterin deficient phenylketonuria detected by neonatal screening in Taiwan -- tPrenatal diagnosis of 6-pyruvoyl tetrahydropterin synthase deficiency in East Asia. -- tHeterogeneity of tetrahydrobiopterin deficiency: combined phenylalaninetetrahydrobiopterin loading test -- tUnusual case of atypical PKU: peripheral or central form of PPH4S deficiency -- tDevelopment of vision in BH4, deficiency -- tFetal guinea-pig model of tetrahydrobiopterin deficiency -- tUnexpected favorable clinical results of therapy in late diagnosed DHPR deficiency -- tSystematic investigation for biopterin defects in hyperphenylalaninemic patients -- tNeuroradiological improvement after one year of therapy in a case of DHPR deficiency -- tV. PTERINS VARIOUS -- tLumazine protein and the bioluminescence of photobacterium -- tBinding of pteridine derivatives to lumazine apoprotein -- tHormonal imbalance by pteridine treatment in diapausing Pieridae induces mutations in the progeny of treated Drosophila melanogaster -- tN-acetyltransferase activity in Pieris brassicae -- tVI. BIOLOGY OF PTERINS -- tPteridines and the immune response. 00t-- tNeopterin elevation and interferon induction in viral diseases -- tTetrahydrobiopterin in human T cells: control of its biosynthesis by interferon-y and interleukin 2 - modulator function in interleukin 2 perception -- tEffects of BH4 on the synthesis of serotonin in brain slices and synaptosomes: implications for the use of BH4 as a therapeutic agent -- tRegulation of cellular proliferation by tetrahydrobiopterin -- tCharacterisation of the mutation in dihydropteridine reductase deficiency -- tUrinary excretion of total pteridines in cancer -- tAlterations of interferon-gamma-induced monocyte activation by immunomodulating compounds determined by neopterin production -- tLevels of neopterin, biopterin, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid of sick neonates and infants -- tUrinary neopterin levels in healthy children -- tUrinary neopterin factor in viral and bacteriological children infections -- tUrinary neopterin levels in liver transplant -- tThe effect of IL-2, neopterin and immunomodulators on neopterin release from macrophages and PBMC -- tMembrane transport of unconjugated pteridines. The model of human erythrocytes. -- tEncephalopathy and abnormal cerebrospinal fluid pteridine profile. Fact or artefact ? -- tInformativity of pteridine measurements in the survey of organ transplantations -- tEffect of triamteren on urinary excretion of pterins in different rat strains -- tPteridines and retinal degenerations in rats and humans -- tPterins in bovine, rat, quail and human retina -- tComparison of urinary biopterin in rats with various housing and enviromental conditions -- tDifferences in the quantity and distribution of urinary pterins in various species of mammals -- tTotal biopterin levels in the ventricular CSF of Parkinson's disease and essential tremor -- tUrinary xanthopterin and derivatives as indicators of liver disease -- tGenetic control of dihydropterin oxidase activity in Drosophila melanogaster -- tA controlled system for supplementation experiments in Drosophila melanogaster -- tNew eye-color mutants affecting the biosynthesis of pteridines and ommochromes in Drosophila melanogaster -- tSearch for 6- and 7-biopterins in human saliva -- tVII. TETRAHYDROBIOPTERIN-DEPENDENT MONOOXYGENASES -- tRegulation of the aromatic amino acid hydroxylases -- tExpression of rat liver dihydropteridine reductase in Escherichia coli -- tEscherichia coli dihydropteridine reductase is a trifunctional enzyme with dihydrofolate reductase activity. -- tRat liver preparations with glyceryl etherase activity -- tPurification and characterization of a membrane associated folate binding protein from human leukemic CCRF-CEM cells -- tOn the effects of high protein diet and of starvation on phenylalanine hydroxylase activities in rats. -- tEffects of experimental diabetes on phenylalanine hydroxylase activities in rats -- tMolecular defects of PKU in Italy differ from those of other European countries -- tThe oxidation of tetrahydropteridines by phenylalanine hydroxylase -- tInteraction of catecholamines and tetrahydropterins with bovine liver phenylalanine hydroxylase -- tStudies of tetrahydrobiopterin uptake in rat brain synaptosomes -- tThe influence of cofactor side-chain chirality on the activity and regulation of phenylalanine and tyrosine and hydroxylases -- tLimited denaturation stimulates tetrahydrobiopterin-dependent activity of rat liver phenylalanine hydroxylase -- tEffect of limited proteolysis on structure and activity of phenylalanine hydroxylase -- tTetrahydropterin as a possible natural cofactor in the Drosophila phenylalanine hydroxylation system -- tInteraction of substrate analog inhibitors with rat liver dihydropteridine reductase -- tSimultaneous purification of phenylalanine hydroxylase, phenylalanine hydroxylase stimulator protein, and dihydropteridine reductase from rat liver -- tVIII. FOLATES -- tA. DIHYDROFOLATE REDUCTASE -- tNMR and mutagenesis studies of dihydrofolate reductase -- tSpectroscopic studies of the interaction of ligands with dihydrofolate reductase -- tComparison between human and bacterial dihydrofolate reductase structures -- tMutagenesis of human dihydrofolate reductase structure as a probe of enzyme function -- tFolate and dihydrofolate reduction by mouse dihydrofolate reductase -- tKinetic mechanism of recombinant human dihydrofolate reductase -- tThe kinetic mechanism of the reaction catalyzed by an R-plasmid (R-67) dihydrofolate reductase from E.coli. -- tMechanism based inhibitors of dihydrofolate reductase. -- tTrimetrexate resistant L. casei and S. faecium -- tSecond site revertants of E. coli dihydrofolate reductase -- tStructural and energetic aspects of the reaction pathway and transition state for hydride-ion transfer in dihydrofolate reductase -- tCloning of trimethoprim-resistant dihydrofolate reductase from multiresistant staphylococci and expression in E. coli -- tRole of TRP-24 in binding and catalysis for human dihydrofolate reductase (DHFR) -- tMutation at hydrophobic residues in dihydrofolate reductase -- tDetermination of the functional role of phenylalanine-31 of recombinant human dihydrofolate reductase by site-directed mutagenesis -- tMolecular modeling studies and crystal structure determination of pteridine antifolate-DHFR enzyme interactions -- tAllelic variants of Chinese hamster dihydrofolate reductase -- tB: THYMIDYLATE SYNTHASE -- tThymidylate synthase - structural and functional considerations -- tDefining the catalytic role of specific amino acids in thymidylate synthase by site-specific mutagenesis -- tStudies of the effects of mutagenesis on a conserved active site arginine residue in thymidylate synthase -- tDual role of serine hydroxymethyltransferase in the synergy of fluorouracil and leucovorin: effects of L-serine and glycine on H4PteGlu/5,10-CH2-H4PteGlu ratios; and H4PteGlu-catalyzed release of fluoride ion from alpha-fluoro-beta alanine. -- tInteraction of N4-hydroxy-dCMP and N4-hydroxy-5-FdCMP with L1210 thymidylate synthase differing in sensitivity towards 5- FdUMP Inhibition -- tMechanism of thymidylate synthase inhibition by N4-Hydroxy-dCMP -- tThymidylate synthase activity in bronchoalveolar lavage cells as a possible marker in lung cancer diagnosis -- tPurification and properties of Hymenolepis diminuta and regenerating rat liver thymidylate synthases -- tInfluence of FdUMP on the binding of methotrexate to thymidylate synthase -- tEfficient expression of mammalian thymidylate synthase in Escherichia coli -- tCatalytic role of histidine-147 in Escherichia coli thymidylate synthase -- tVariation among human thymidylate synthase enzymes in folate affinity -- tEvaluation of in vivo inhibition of thymidylate synthase in patients with colorectal cancer treated with 5-fluorouracil -- tEffect of leucovorin on 5-fluorouracil induced inhibition of thymidylate synthase in murine colon cancer -- tFeedback inhibition of thymidylate synthase by dihydrofolate polyglutamates cannot account for partial depletion of tetrahydrofolate cofactors by antifolates -- tKinetic studies on thymidylate synthase from Lactobacillus casei -- tC. METHIONINE SYNTHASE -- tStudies on the cobalamin-dependent methionine synthase from Escherichia coli K12 -- tFoimyl phosphate as an intermediate in the N10-formyltetrahydrofolate synthetase reaction. -- tEnzymes of homocysteine remethylation and transsulfuration in methionine or cholesterol induced atherosclerosis in rabbits -- tBiochemical changes in porcine neural tissue after inactivation of methionine synthase by nitrous oxide. -- tIncreased synthesis of AdoMet but not of methionine during testosterone stimulation of polyamine biosynthesis in mouse kidney -- tD. ENZYMOLOGY AND METABOLISM -- tRole of folylpolyglutamate synthetase in the regulation of folate and antifolate metabolism. -- tNAD-dependent methylenetetrahydrofolate dehydrogenase-cyclohydrolase present in transformed mammalian cells -- tGammaglutamyl hydrolases -- tHuman methenyltetrahydrofolate synthetase -- tFolate catabolism in man and the rat -- tEffects of growth rate on y-glutamyl hydrolase in Ehrlich ascites carcinoma cells -- tFolylpolyglutamate synthesis in Neurospora crassa. 00tWild type FPGS activity and transformation of polyglutamate deficient mutants using cosmid vectors containing the met-6 gene -- tCloning and expression of the gene encoding Lactobacillus casei folylpolyglutamate synthetase in Escherichia coli -- tEffect of treatments with different anticonvulsant drugs on folate pattern in rat liver. -- tA sensitive new microassay useful for measurement and purification of mammalian folylpolyglutamate synthetase -- tTissue differences in N5 formyltetrahydrofolate metabolism -- tE. FOLATES IN ENDOGENOUS PURINE METABOLISM -- tGlycinamide ribonucleotide transformylase from E. coli: characterization and inhibition. -- tEstimation of the flux control coefficient of glycineamide ribonucleotide transformylase for purine biosynthesis de novo -- tMonocyclic 5-deazatetrahydrofolate analogues as inhibitors of de novo purine biosynthesis -- tInhibition of glycinamide ribonucleotide transformylase, methotrexate transport, and the growth of MCF-7 cells by 5,8-dideazafolates -- tF. FOLATES, VARIOUS -- tFormation of methylcobamide from methyltetrahydrofolate by acetogenic bacteria: enzymology and redox chemistry. -- tIncorporation of the ring carbon of histidine into coenzymes of folylpolyglutamates. -- tIn vivo effect of folic acid on fragile-site expression -- tIX. ANTIFOLATES -- tA. DEAZADERIVATIVES -- tNew synthetic studies on deazafolates -- tMolecular modeling studies on deazatetrahydrofolates -- tBiochemical pharmacology of deazatetrahydrofolates -- tSynthesis and evaluation of l-deaza-7,8-dihydropteridines and ring analogues -- tIn vitro and in vivo activity of the GAR transformylase inhibitor 5-deazacyclotetrahydrofolate -- tvitro and in vivo studies with 2-desamino-2-CH3-N10-propargyl-5,8- dideazafolate (ICI 198583), an inhibitor of thymidylate synthase -- tComparative studies on the activity of methotrexate and the analog 10-ethyl-10-deaza-aminopterin (10-EdAM) against head and neck carcinoma cell lines and xenografts. -- tTransport of 5,10-dideazatetrahydrofolic acid (DDATHF) in CCRF-CEM sensitive and methotrexate resistant cell lines -- tSynthesis and structure-activity relationship studies of 5,10- dideazatetrahydrofolic acid (DDATHF) -- tSynthesis and antifolate properties of 5-alkyl-5-deazaaminopterin analogues modified in the 10-position -- tSynthesis and biological evaluation of 2-desamino-2-methyl-5,10- dideazatetrahydrofolate -- tQuinazoline antifolate thymidylate synthase inhibitors: potent cytotoxic agents containing heterocyclic isosteres of the para-amino benzoate unit -- tAntifungal activity of some 2,4-diamino-5-methyl-6-alkyl quinazoline -- tMembrane transport characteristics of the thymidylate synthase inhibitor 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid. -- tSynthesis and potential antitumor activity of 5-deaza analogs of 5,10- methylenetetrahydrofolic acid -- tTheoretical studies of the structures and conformations of triazine antifolates -- tIn vitro and in vivo metabolism of 5-DACTHF, an acyclic tetrahydrofolate analog -- tMeasurement of retained thymidylate synthase (TS) inhibition by antifolates in whole cells in vitro -- tSubstitution on the benzene ring of quinazoline antifolates that inhibit thymidylate synthase -- tInhibition of de novo purine synthesis by deazatetrahydrofolates -- tB.Methotrexates -- tResistance to methotrexate in experimental models and in patients -- tMethotrexate peptides as cancer chemotherapeutic agents -- tBiochemical determinants of methotrexate selectivity -- tMechanisms underlying methotrexate inactivity in human head and neck cancer xenografts -- tDesign and synthesis of novel methotrexate derivatives for antibody directed drug targeting -- tMethotrexate (MTX) transport and cytotoxity of MTX and trimetrexate (TMQ) for human squamous cell carcinoma (SCC) of the head and neck grown at low folate concentrations -- tFolate enhancement of antifolate synergism in lymphoma cells -- tAmino acid oxidation and dihydrofolate reductase inactivation photosensitized by a diaminopteridine -- tSynchronisation of U937 and SW626 cancer cell lines of human origin using methotrexate -- tNew inhibitors of plasmodial folate synthesis - comparison of cell-free, whole cell and in vivo activities for single drugs and drug combinations -- tEffect of vincristine on methotrexate cytotoxicity and accumulation in MCF-7 cells, a human breast cancer cell line -- tThe y-tetrazole analog of methotrexate: design, synthesis and biological activity -- tEffect of intravenous 24 hr infusions of methotrexate on unconjugated pteridine metabolism -- tCovalent labeling of dihydrofolate reductase and folate transport proteins by fluorescein methotrexate -- tStudy of methotrexate polyglutamate formation in cultured leukemic cells -- tC. Various Antifolates -- tFolyl polyglutamates in metabolism and chemotherapy -- tBiological determination of selective antitumor action of 4-amino-folate analogs -- tInhibition of the thymidylate synthase cycle of leukemia cells by antifolates: The usefulness of the cellular tritium release assay -- tFluoroglutamate-containing folates and antifols: probing the role of polyglutamylation in vitro -- tTherapeutic strategies for 5-fluorouracil-leucovorin based upon cellular metabolic characteristics in human colon adenocarcinoma xenografts -- tThe lack of response of human colonic tumor cell lines to biochemical modulation by folinic acid. -- tFolinic acid as a source of intracellular 5,10-methylenetetrahydrofolate in human carcinoma cells -- tStructure activity relationships of multidrug resistance -- tEnhancement of the cytotoxicity of fluoropyrimidines to human carcinoma cell lines by leucovorin -- tD. Transport And Absorption Of Folates And Antifolates -- tMethotrexate transport via the high-affinity folate binding protein of L1210 cells. -- tCombined affinity and ion pair liquid chromatographies for direct analysis of tissue folate composition -- tTumor cell sensitivity and resistance to folate analogues: the role of carrierand receptor-mediated transport systems -- tLysosomal permeability to methotrexate polyglutamates -- tFolic acid metabolism in placental cells associated with neural tube defects -- tHomologous membrane folate binding proteins in human placenta -- tA high-affinity folate binding protein in human amniotic fluid -- tInteraction of N-hydroxy(sulfo)succinimide active esters with the reduced folate/methotrexate transport system from human CCRF-CEM leukemia cells -- tRenal uptake and metabolism of 5-methyltetrahydrofolate in the rat -- tMethotrexate- and folate-lipid conjugates of defined chemical structures as new antifolate analogs and transport probes -- tCharacterization of receptor-mediated (anti)folate uptake in human CCRF-CEM cells -- tAuthor Index -- tSubject Index -- tList of Participants -- tBackmatter0 arestricted accessuhttp://purl.org/coar/access_right/c_16ecfonline access with authorization2star  aIssued also in print.  aMode of access: Internet via World Wide Web.  aIn English.0 aDescription based on online resource; title from PDF title page (publisher's Web site, viewed 01. Dez 2022) 0aPteridinesvCongresses. 7aSCIENCE / General.2bisacsh1 aBlau, Nenad, eeditor.4edt4http://id.loc.gov/vocabulary/relators/edt1 aCurtius, Hans-Christoph, eeditor.4edt4http://id.loc.gov/vocabulary/relators/edt1 aGhisla, Sandro, eeditor.4edt4http://id.loc.gov/vocabulary/relators/edt08iTitle is part of eBook package:dDe GruytertDGBA Reference Works 1990 - 1999z9783110637335oZDB-23-GRW0 cprintz978311012199540uhttps://doi.org/10.1515/978311088900040uhttps://www.degruyter.com/isbn/9783110889000423Coveruhttps://www.degruyter.com/document/cover/isbn/9783110889000/original  aEBA_BACKALL  aEBA_DGALL  aEBA_EBACKALL  aEBA_EBKALL  aEBA_EEBKALL  aEBA_ESTMALL  aEBA_STMALL  aGBV-deGruyter-alles  aPDA12STME  aPDA13ENGE  aPDA18STMEE  aPDA5EBK  aZDB-23-GRWc1990d1999